from broker MB,
*******Upgrade to the top rating
****************upgraded to $20.00 (from $15.30),
Flight Centre Travel Group (FLT AU)
Preparing for take-off
Key points
1H21 challenged but outlook supported by pent up demand and a leaner
business model. Leisure and Corporate expected to breakeven in CY21.
Cash reserves adequate; available cash of ~$800m should be sufficient
until late CY22 at current run rate & assuming min. revenue improvement.
Upgrade to OP (from N). Stock remains highly sensitive to +ve news flow &
valuation supported by strong macro conditions
With vaccines being rolled out, travel recovery may have seen its last
delay. While 1H21 was challenged (TTV: -88% and revenue -90%), FLT
expects both Leisure & Corporate to breakeven during CY21 with TTV
recovering to pre-COVID levels in FY24 (we assume an 80-85% recovery)
Earnings and target price revision
• FY21/22/2 EPS n.m./+24%/+14% driven by cost benefits/ op leverage. PT
upgraded to $20.00 (from $15.30), reflecting earnings changes & reduced
risk discount in FY24 (by 1/3) with vaccine rollout now underway.
- Forums
- ASX - By Stock
- Research - DJUSTT
from broker MB,*******Upgrade to the top...
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.06 |
Change
-0.440(2.15%) |
Mkt cap ! $4.432B |
Open | High | Low | Value | Volume |
$20.48 | $20.51 | $19.96 | $22.27M | 1.108M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 425 | $20.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.06 | 2865 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 425 | 20.020 |
1 | 496 | 20.000 |
2 | 5180 | 19.990 |
5 | 11118 | 19.980 |
3 | 7782 | 19.970 |
Price($) | Vol. | No. |
---|---|---|
20.060 | 2865 | 1 |
20.070 | 3816 | 3 |
20.090 | 2632 | 2 |
20.110 | 320 | 1 |
20.120 | 2317 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$19.99 |
  |
Change
-0.440 ( 2.47 %) |
|||
Open | High | Low | Volume | ||
$20.50 | $20.50 | $19.95 | 269417 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
FLT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online